Literature DB >> 7875481

Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction.

J C Wu1, T Z Chen, Y S Huang, F S Yen, L T Ting, W Y Sheng, S H Tsay, S D Lee.   

Abstract

BACKGROUND/AIMS: Polymerase chain reaction (PCR) is very sensitive. The aim of the study was to reevaluate viral replication in hepatitis D virus (HDV) superinfection by PCR.
METHODS: HDV and hepatitis B virus (HBV) were detected by PCR in 185 patients.
RESULTS: The acute hepatitis group had the highest detection rate of HDV RNA compared with chronic hepatitis, cirrhosis, hepatocellular carcinoma, and remission groups (63 of 64 vs. 35 of 47, 17 of 23, 19 of 30, and 7 of 21) and the highest alanine aminotransferase (ALT) levels (mean, 1741 U/L vs. 266 to 27 U/L; P < 0.05). The detection rate of HBV DNA was the lowest in the acute group (41%) compared with 66%, 70%, 80%, and 57% in the remaining groups (P < 0.02). At the chronic stage, 13%-25% of cases had HDV RNA, and 30%-48% of cases had HBV DNA detected by PCR but not by traditional method. HDV RNA was associated with ALT levels in horizontal and longitudinal analyses.
CONCLUSIONS: HDV superinfection may be divided into the following three phases: acute phase, active HDV replication and suppression of HBV with high ALT levels; chronic phase, decreasing HDV and reactivating HBV with moderate ALT levels; and late phase, development of cirrhosis and hepatocellular carcinoma caused by replication of either virus or remission resulting from marked reduction of both viruses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875481     DOI: 10.1016/0016-5085(95)90453-0

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  26 in total

1.  Current concept in the pathophysiology of hepatitis delta infection.

Authors:  Grazia Anna Niro; Antonina Smedile
Journal:  Curr Infect Dis Rep       Date:  2012-02       Impact factor: 3.725

2.  Current prevalence of hepatitis delta virus (HDV) infection and the range of HDV genotypes in Lebanon.

Authors:  S Ramia; M El-Zaatari; A I Sharara; F Ramlawi; B Farhat
Journal:  Epidemiol Infect       Date:  2006-12-19       Impact factor: 2.451

Review 3.  Hepatitis D virus coinfection and superinfection.

Authors:  Francesco Negro
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  Hepatitis D Virus: A Call to Screening.

Authors:  Joseph Ahn; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-10

5.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

6.  "Defective" mutations of hepatitis D viruses in chronic hepatitis D patients.

Authors:  Jaw-Ching Wu; Sheng-Chieh Hsu; Shen-Yung Wang; Yi-Hsiang Huang; I-Jane Sheen; Hsuan-Hui Shih; Wan-Jr Syu
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

Review 7.  Hepatitis D and hepatocellular carcinoma.

Authors:  Zaigham Abbas; Minaam Abbas; Sarim Abbas; Lubna Shazi
Journal:  World J Hepatol       Date:  2015-04-18

8.  Large hepatitis delta antigen is not a suppressor of hepatitis delta virus RNA synthesis once RNA replication is established.

Authors:  Thomas B Macnaughton; Michael M C Lai
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Hepatitis B surface antigen levels and sequences of natural hepatitis B virus variants influence the assembly and secretion of hepatitis d virus.

Authors:  Hsuan Hui Shih; King-Song Jeng; Wan-Jr Syu; Yi-Hsiang Huang; Chien-Wei Su; Wei-Li Peng; I-Jane Sheen; Jaw-Ching Wu
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

10.  Interaction and replication activation of genotype I and II hepatitis delta antigens.

Authors:  Sheng-Chieh Hsu; Jaw-Ching Wu; I-Jane Sheen; Wan-Jr Syu
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.